Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 May;82(5):1217-1218.
doi: 10.1016/j.jaad.2020.03.031. Epub 2020 Mar 19.

Should biologics for psoriasis be interrupted in the era of COVID-19?

Mark Lebwohl  1 , Ryan Rivera-Oyola  2 , Dedee F Murrell  3
Affiliations

Should biologics for psoriasis be interrupted in the era of COVID-19?

Mark Lebwohl et al. J Am Acad Dermatol. 2020 May.
No abstract available

PubMed Disclaimer

Comment in

References

    1. Gee K., Guzzo C., Che Mat N.F., Ma W., Kumar A. The IL-12 family of cytokines in infection, inflammation and autoimmune disorders. Inflamm Allergy Drug Targets. 2009;8(1):40–52. - PubMed
    1. Reich K., Ortonne J.P., Gottlieb A.B., et al. Successful treatment of moderate to severe plaque psoriasis with the PEGylated Fab' certolizumab pegol: results of a phase II randomized, placebo-controlled trial with a re-treatment extension. Br J Dermatol. 2012;167(1):180–190. - PubMed
    1. Ortonne J.P., Taïeb A., Ormerod A.D., et al. Patients with moderate-to-severe psoriasis recapture clinical response during re-treatment with etanercept. Br J Dermatol. 2009;161(5):1190–1195. - PubMed
    1. Blauvelt A., Papp K.A., Sofen H., et al. Continuous dosing versus interrupted therapy with ixekizumab: an integrated analysis of two phase 3 trials in psoriasis [published correction appears in J Eur Acad Dermatol Venereol. 2017;31(10):1764] J Eur Acad Dermatol Venereol. 2017;31(6):1004–1013. - PMC - PubMed

MeSH terms

Substances